Professional Documents
Culture Documents
GLP-1 Secretion As A Prerequisite For The Antidiabetic Activity of DPP-4 Inhibitors: Can It Be Modified?
GLP-1 Secretion As A Prerequisite For The Antidiabetic Activity of DPP-4 Inhibitors: Can It Be Modified?
Fiona M Gribble
Cambridge Institute for Medical Research, UK
Underlying basis for the incretin effect
appetite
insulin
Vagal
DPP4
GLP-1
L-cell peptides
Ingested food
insulin release
(incretin effect)
GLP-1
L-cell peptides PYY appetite
Oxyntomodulin
GLP-2
Epithelial regeneration
Food ingestion
K-cells GLP-1
(GIP) secretion
Other GI
hormones
• CCK L-cells
• 5-HT
• neurotensin
• ghrelin
• somatostatin
• secretin
How are L cells stimulated physiologically ?
Sugars
Peptides
Fats
Bile acids
Hormonal
/ paracrine?
Receptors?
Uptake? GLP-1
release
Metabolism?
Neural?
Studying L-cell function in vivo
Venus-fluorescent L-cells
L-cells are electrically active and nutrient responsive
40
V (mV)
0
-40
60 s
glucose
40
V (mV)
-40
500 ms
Activity dependent GLP-1 release
Ca2+
GLP-1
secretion
Ca2+
Luminal
Na+
signal
How do L-cells sense?
Nutrient Na+, H+
Electrogenic GPCR
uptake
ATP
Ca2+
KATP
channel
SGLT1 as a glucose sensor in primary L-cells
GLP-1small
Upper secretion
intestine
Small intestinal villus
secretion
2.5 ** **
19 12
release
2.0
GLP-1
1.5
GLP-1
1.0
Relative
Venus
SGLT1
0.5
Con Gluc αMG
SGLT1 Expression
Relative mRNA expression
2.2
GLP-1 release
0.4 FACS
0.3 L+ 1.8
0.2 L- 1.4
0.1 1.0 EC50 0.2 mM
0 0.6
α β δ/pp
GLUTag
L+ L- L+ L- 0.1 1 10 100
SI colon [αMG] (mM)
A working model for luminal nutrient detection
Ca2+
Amino acid GLP-1
transporters secretion
PEPT Ca2+
Na+
Glucose
H+
Na+
SGLT1
Na+
Expression of KATP channel subunits and glucokinase
Kir6.2 3 SUR1
0.4
0.3 2
0.2
Expression relative to β-actin by qRT-PCR
1
0.1
0 0
α β δ/pp
GLUTag
α β δ/pp
GLUTag
L+ L- L+ L- L+ L- L+ L-
SI colon SI colon
Glucokinase
0.12
0.08
0.04
0
β
GLUTag
L+ L- L+ L-
SI colon
What is the role of L-cell KATP channels?
Neurotransmitters?
Plasma glucose?
KATP channels
+
K +
K
Luminal
glucokinase
nutrients
Na++
Na
Na+
+
Na
H+
How might you target L-cells therapeutically?
Ca2+
GLP-1
secretion
Ca2+
Na+
cAMP
GLP-1 secretion from primary colonic L-cells – importance of cAMP
†††
12 6
***
Relative GLP-1 secretion 10
8 9
***
6
†††
7
4 *** 13
14 ***
*** ***
29 3
2
**
0
Con Fsk/IBMX PMA Bombesin SS
glucose - + - + - - + -
Monitoring dynamic cAMP changes in GLUTag cells using FRET sensors
Modified cAMP
binding protein
cAMP
520nm
Cyan Yellow
M.Lohse
430nm
FRET: excite cyan, detect yellow
100 µ M IBMX
1 µ M Forskolin
10 µ M Forskolin
1.20
CFP/YFP
1.15
1.10
1.05
1.00 1 min.
Gαs-coupled receptors under therapeutic evaluation
0.2
GPR119
0.16
0.12
Expression relative to β-actin by qRT-PCR
0.08
0.04
0
L- α β
GLUTag
K+ K- L+ L- L+
SI SI colon
GPBAR
0.02
(TGR5 / GPR131)
0.01
0
L- α β
GLUTag
K+ K- L+ L- L+
SI SI colon
Adaptation of enteroendocrine cells in vivo?
Nutritional Surgical
Genetic
??
Inflammatory
∆ L-cell number/function
Therapeutic
Metabolic
With thanks to:
Abdella Habib
Gwen Tolhurst
Helen Parker
Gareth Rogers
Asan Ramzan
Ronn Friedlander
Frank Reimann
Ria Diakogiannaki
Katie Moss
Daisuke Fukuoka